Navigation Links
Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance
Date:5/8/2012

ALLEGAN, Mich., May 8, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced results for its third quarter ended March 31, 2012.

(Logo:  http://photos.prnewswire.com/prnh/20120301/DE62255LOGO)

Perrigo's Chairman and CEO Joseph C. Papa commented, "We are very pleased with our record fiscal third quarter revenue and earnings performance. These strong results were made possible by the continued operational excellence of the team. Headlining this execution were the $64 million in new product launches, mostly in OTC, which keep us on track to exceed our $190 million new product sales goal for fiscal 2012. Global Consumer Healthcare sales grew 6% in the quarter, driven mainly by U.S. OTC sales growth of 8% despite a historically mild cough/cold and flu season. In Nutritionals, we were able to improve adjusted margins from last quarter as measures put in place partially offset the volatility in raw materials pricing. Our Rx segment continues to exceed our expectations in both our existing and newly acquired business. We are continuing to make quality healthcare more affordable to consumers around the globe."

Refer to Table I at the end of this press release for adjustments in the current year and prior year periods and additional non-GAAP disclosure information.

The Company's reported results are summarized in the attached Condensed Consolidated Statements of Income, Balance Sheets and Statements of Cash Flows.Perrigo Company(from continuing operations, in thousands, except per share amounts)(see the attached Table I for reconciliation to GAAP numbers)Third Quarter

Nine Months2012201120122011Net Sales

$778,017

$691,563

$2,341,482

$2,050,400Reported Income

$115,727

$91,531

$285,924

$254,988Adjusted I
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
2. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
3. Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
4. Perrigo Confirms Filing for Generic Version of Mens Rogaine(R) Foam
5. Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
6. Perrigo Company Announces Dividend Increase
7. Perrigo Company Announces Quarterly Dividend
8. Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010
9. Perrigo Company to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Perrigo Company To Present at the Sidoti Emerging Growth Conference
11. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... TOKYO , May 30, 2015  Astellas Pharma ... a Phase 1/2 trial on the safety, tolerability and ... patients with relapsed or refractory (R/R) acute myeloid leukemia ... the American Society of Clinical Oncology,s (ASCO) annual meeting ... is a receptor tyrosine kinase inhibitor of FLT3 and ...
(Date:5/30/2015)... Tex. , May 30, 2015 ... on fulfilling the promise of precision medicine, today ... that demonstrate the utility of Caris Molecular Intelligence®, ... facilitating comparisons between tumors that share histological features. ... the American Society of Clinical Oncology (ASCO) in ...
(Date:5/29/2015)... 2015  Excite Medical was established by its President, ... Excite Medical, under the leadership of Mr. Musallam ... a solid track record of providing unparalleled service and ... base.  Photo - http://photos.prnewswire.com/prnh/20150529/219412 ... been possible, in large part, due to Mr. ...
Breaking Medicine Technology:Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML) 2Astellas Announces Preliminary Phase 1/2 Safety, Tolerability And Efficacy Data For ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML) 3Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 2Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 3Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 4Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 5Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 6
(Date:5/30/2015)... Chicago, Ill. (PRWEB) May 30, 2015 ... academicians were recognized by their peers as the 2015 ... hosted by OncLive® at the Chicago Illuminating Company last ... panel of eminent oncologists for landmark achievements in translational ... has changed the course of cancer treatment. , Honorees ...
(Date:5/30/2015)... 2015 Thousands of aesthetic industry professionals ... sponsored by the American Society for Aesthetic Plastic Surgery ... was Zeltiq, the parent company of one of the ... With blazing growth, the one-of-a-kind device just sold its ... is currently in the news for gaining the FDA’s ...
(Date:5/30/2015)... 30, 2015 On Thursday, May ... Charles Simone and Dr. Evan Alley both of ... the Mesothelioma Experts’ series. The interview was part ... centers of excellence. Drs. Simone and Alley were ... Hesdorffer, with whom they discussed the mesothelioma program ...
(Date:5/30/2015)... Industry, CA (PRWEB) May 30, 2015 ... technology and foreign travelers who experienced OGAWA products while ... in the U.S. , A leader in the ... is a cutting-edge designer, researcher, developer and manufacturer of ... longevity and superior craftsmanship of their products, health enthusiasts ...
(Date:5/30/2015)... Cyclist Barry Haarde will commence his ... 2015: Piles of Miles” near San Francisco, California ... and encourage individuals to support needy hemophilic children ... Life supports nearly 1,200 impoverished children and adults ... sponsorships, scholarships and micro-enterprise grants. Hemophilia is a ...
Breaking Medicine News(10 mins):Health News:OncLive’s 2015 Giant of Cancer Care™ Awards Announced 2Health News:OncLive’s 2015 Giant of Cancer Care™ Awards Announced 3Health News:OncLive’s 2015 Giant of Cancer Care™ Awards Announced 4Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 2Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 3Health News:Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand 2Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 2Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 3Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2
... placenta may damage blood vessels in women with preeclampsia ... to life-threatening increases in high blood pressure after 20 ... substances called "microparticles" released by the placenta damage maternal ... by Seth Guller, sought to detect whether specific proteins ...
... mutation that causes X-linked mental retardation for which there ... study. ,Investigators F. Lucy Raymond, ... Sanger Institute, UK describe the ZDHHC9 gene found in ... point of entirely losing function. ,"ZDHHC9 ...
... A new calibration technique that involves measuring the distance ... help facial plastic surgeons// use computer imaging software, according ... facial proportions has been studied for centuries by architects, ... information in the article. It is essential for plastic ...
... who treat them have incorporated spirituality into the recovery ... how spirituality changes during recovery, or how those changes ... quest for sobriety. ,Now, a new study ... Center sheds light on this phenomenon. In the March ...
... developed a malaria-resistant mosquito, a step that might one day ... millions// of lives around the world. ,When ... higher survival rate than nonresistant ones, meaning they could eventually ... a report in Tuesday's issue of Proceedings of the National ...
... by the National Aeronautics and Space Administration (NASA) has ... has been thinning// since early 1990s. ,Aerosols ... naturally, originating from volcanoes, dust storms, forest and grassland ... tend to cause cooling of the Earth's surface immediately ...
Cached Medicine News:Health News:Severe Mental Retardation Gene Mutation Identified 2Health News:Computer Imaging Assists With Facial Reconstructive Surgery 2Health News:Spirituality Increases as Alcoholics Recover 2Health News:Spirituality Increases as Alcoholics Recover 3Health News:Malaria-resistant Mosquito Developed 2
... laser beam is delivered through an ultra thin ... the operator full freedom of movement when performing ... with a wide range of handpieces. Handpieces ... mm and 16 mm. Straight and angled ...
These are the Reusable Components (minus cannula), to be used with the VersaStep™ Plus Reposable Short System....
... VERSASTEP™ Plus Short Instrument for ... ,The VERSASTEP™ Plus Short ... Length is a unique endoscopic ... in laparoscopic procedures. It is ...
... Autosuture™ Blunt Tip Trocar consists of a ... a valve body assembly. , ,The ... valve and seal to prevent gas leakage ... Autosuture™ Blunt Tip Trocar includes built-in converters ...
Medicine Products: